Vildagliptin-Associated Acquired Hemophilia A

Abstract

Get full access to this article

View all access options for this article.

References

Tiede

Collins

Knoebl

, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020;105(7):1791-1801. doi:10.3324/haematol.2019.230771

Hibino

Takahashi

Yamaguchi

, et al. Acquired hemophilia A following administration of dipeptidyl peptidase-4 inhibitors: a case report and literature review. Int J Hematol. 2022;115(2):270-274. doi:10.1007/s12185-021-03165-6

Naranjo

Busto

Sellers

, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245. doi:10.1038/clpt.1981.154

Mentlein

Dipeptidyl-peptidase IV (CD26)—role in the inactivation of regulatory peptides. Regul Pept. 2004;115(2):75-84. doi:10.1016/j.regpep.2003.12.021